
    
      After obtaining written informed consent, patients of clinically diagnosed with bilateral CTS
      were randomized into intervention and control side. Intervention group received one-dose
      ultrasound-guided PRP injection and control group received one-dose ultrasound-guided normal
      saline injection. No additional treatment after injection through the study period. The
      primary outcome is Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) and secondary outcomes
      include visual analog scale (VAS), cross-sectional area (CSA) of the median nerve, sensory
      nerve conduction velocity of the median nerve, and finger pinch strength. The evaluation was
      performed pretreatment as well as on the 2nd week, 1st, 3rd, 6th month and one year after the
      treatment.
    
  